[e-farmacos] Prescrire International-octubre 2001

["Canas, Martin" <macanas@netverk.com.ar>]

E-farmacos: Prescrire International-octubre 2001
-------------------------------------------------------------------------

Amigos,

Salio un nuevo numero de Prescrire International. La informacion sobre
las tarifas solidarias al final.

Saludos,

Martin


Martin Canas(con enie y acento)
Fundacion Femeba/Gapurmed
(Argentina)
macanas@netverk.com.ar



October 2001 Volume 10, No 55

EDITORIAL
Press sources

NEW PRODUCTS
Venlafaxine (new indication)
Poorly established efficacy in generalised anxiety disorder
Mifepristone (new indication)
May help women undergoing vacuum aspiration of pregnancy
Sibutramine (new preparation)
No place in the management of obesity
News of Prescrire's Reps Monitoring Network
Pretences and off-label claims

ADVERSE EFFECTS
Low molecular weight heparin and pregnancy
Severe liver damage with leflunomide
Severe hepatitis due to Atrium
Disopyramide: interactions with macrolide antibiotics
Urinary disorders on tramadol

REVIEWS
Choosing an anticoagulant during pregnancy
Unfractionated heparin is still the reference
Homeopathic arnica: just a placebo
Results of four placebo-controlled trials

OUTLOOK
Drugs agencies' websites under scrutiny

SHORTCUTS
Managing type 2 diabetes - Etonogestrel subcutaneous
implant - Lercanidipine


Tarifas de suscripcion solidaria para paises con PBI < 10,000 USD*:
Individuos = 35 USD (FF 250 or 38.11 Euro)
Estudiantes = 21 USD (FF 150 or 27. 87 Euro)
Instituciones = 85 USD (FF 600 or 91. 47 Euro) (excepto companhias
farmaceuticas)

*los siguientes paises NO son elegibles para las tarifas de suscripcion
solidaria:
Australia, Austria, the Bahamas, Belgium, Brunei, Canada, Cyprus,
Denmark, Finland, France, Germany, Greece, Hong Kong, Iceland, Ireland,
Israel, Italy, Japan, Kuwait, Liechtenstein, Luxembourg, Monaco, the
Netherlands, New Zealand, Norway, Portugal, Qatar, Singapore, Spain,
Sweden, Switzerland, United Kingdom, United Arab Emirates, United States
of America.

Prescrire International
BP 459
75527 Paris Cedex 11
Tel: 33 1 49 23 72 65
Fax: 33 1 48 07 87 32
International@prescrire.org


[NOTA: Mensaje sin acentos ni caracteres especiales.]
-
Envíe el correo para la conferencia de `e-farmacos' a:
e-farmacos@usa.healthnet.org
Envíe las peticiones administrativas a:
majordomo@usa.healthnet.org
Para la ayuda adicional, envíe el correo a:
owner-e-farmacos@usa.healthnet.org